<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163095</url>
  </required_header>
  <id_info>
    <org_study_id>REB16-1588-the COOL study</org_study_id>
    <nct_id>NCT03163095</nct_id>
  </id_info>
  <brief_title>Closed or Open Abdomen for the Management of Abdominal Sepsis</brief_title>
  <official_title>Closed Versus Open Abdomen in the Surgical Treatment of Severe Secondary Peritonitis: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alberta Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized clinical study. The study will comprise the randomized
      decision to either A) primarily close the fascia after laparotomy for intra-abdominal
      infection (CLOSED); or B) leave the fascia open after laparotomy and apply a temporary
      abdominal closure (TAC) device (OPEN) with a vacuum drain.

      Although debatable, both procedures (CLOSED or OPEN abdomen) are acceptable based on current
      suggested standard of care. Thus, high quality data to direct clinical decision making in
      this highly lethal condition is urgently required.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe complicated intra-abdominal sepsis (SCIAS) is a World-Wide challenge, with high
      mortality rates, and ever increasing incidence. Most cases are subjected to secondary
      peritonitis in which there is a physical disruption of the integrity of the gastrointestinal
      (GI) tract leading to contamination of the peritoneal cavity. Ultimately, the resultant organ
      damage results in auto-amplifying biomediator generation and systemic inflammation. Mortality
      rates range from 10% to over 40% when shock is present. The key principles of treating SIAS
      are early antibiotic administration and the earliest possible operative intervention to
      provide source control of GI perforations/disruptions. A further potential therapeutic option
      may be to utilize open abdomen (OA) management with active negative peritoneal pressure
      therapy (ANPPT) to remove intra-peritoneal inflammatory ascites and to ameliorate the
      systemic damage from SCIAS. Recent data from a randomized controlled trial including either
      severe peritonitis or trauma patients, showed the 30-days mortality differed between
      commercial open abdomen systems and non-commercial technique, which favored the more
      effective commercial device. Although there is a biologic rationale for such an intervention
      from animal models as well as non-standardized clinical utilization currently, the open
      abdomen management with ANPPT remains a novel therapy with much clinical equipoise. Thus, the
      Closed Or Open after Laparotomy (COOL) study will constitute a prospective randomized
      controlled trial to address this issue.

      There is a complex relationship between pressure, ischemia, and inflammation within the
      peritoneal cavity. Independently the damaged gut seems to act as a continued source of
      inflammation propagating systemic inflammatory response syndrome (SIRS) and potentiating
      multi-organ dysfunction syndrome (MODS). Although extremely complicated, visceral ischemia
      further generates multiple immunological mediators with the pro-inflammatory cytokines tumor
      necrosis factor-alpha (TNF-α), and interleukin 6 (IL-6), as well as inhibitive cytokines such
      as interleukin 10 (IL-10). Post-operative complications associate with increasing levels of
      systemic IL-6, and peritoneal TNF-α. Jansson and colleagues believe that peritoneal cytokines
      in humans respond more extensively compared to systemic cytokines, and that a normal
      postoperative course is characterized by decreasing levels of peritoneal cytokines based on
      studies of both elective and emergency surgery. Overall, the peritoneal cytokine response is
      much higher than the systemic response in peritonitis.

      ANPPT therapy may be a more direct and focused solution to this complicated problem, and that
      will be complementary to the other benefits of open abdomen management in the sickest
      patients. Whether improved post-operative courses can be obtained through this relatively
      simple approach of actively removing peritoneal cytokines in humans is therefore a secondary
      objective of this trial.

      Another potential benefit of ANPPT after severe infection may be the attendant decompression
      of the abdominal compartment and prevention of even modest degrees of intra-abdominal
      hypertension (IAH). Patients with intra-abdominal infections are at risk of elevated
      intra-abdominal pressure (IAP) both as a result of the primary intra-peritoneal disease, and
      as large fluid resuscitation often required maintaining organ perfusion. Recent studies have
      demonstrated a high prevalence of IAH following aggressive resuscitation of septic patients.
      Intra-abdominal hypertension is present in as many as 80% of septic medical and surgical ICU
      patients. Reintam also reported that septic patients with IAH had a 50% rate of mortality
      compared to 19% without IAH, making IAH a significant marker for an increased risk of death.
      Within our own institution, rates of IAH were over 87% of septic ICU patients and further 61%
      of these patients had severe IAH at levels commensurate with abdominal compartment syndrome
      (ACS). Although direct translation to humans is uncertain, even modest degrees of IAH (often
      clinically ignored) have been found to have profound effects on propagating multiple organ
      failure in animals with ischemia/intra-peritoneal infections.

      The study intervention will comprise the randomized decision to either A) primarily close the
      fascia after laparotomy for SCIAS (CLOSED); or B) leave the fascia open after laparotomy for
      SCIAS and apply an ANPPT temporary abdominal closure (TAC) device (OPEN).

      Patients will be randomized intra-operatively once it is determined that COMPLICATED and
      SEVERE Intra-Abdominal Infection (SCIAS) is present. SEVERE will be defined and denoted by
      the presence of any organ dysfunction exemplified by septic shock OR a
      Predisposition-Infection-Response-Organ Dysfunction Score &gt; 3 or a
      World-Society-of-Emergency-Surgery-Sepsis-Severity-Score &gt; 8, and COMPLICATED with the
      presence of purulent, feculent, or enteric spillage over at least 2 intra-peritoneal
      quadrants.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization by blocks on a website.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Research members in the laboratory will be blinded with participants' clinical data.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The numbers of participants who are survival in hospital stay</measure>
    <time_frame>90 days after participants enrolled in the study</time_frame>
    <description>The rate of survival of participants in both arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The days of intensive care unit stay</measure>
    <time_frame>30 days after participants enrolled in the study</time_frame>
    <description>The median length of days in ICU needed by participants in both arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The pg/ml of blood Interleukin-6</measure>
    <time_frame>72 hours after participants enrolled in the study</time_frame>
    <description>The mean concentrations of blood IL-6 in participants in both arms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Abdominal Sepsis</condition>
  <condition>Abdominal Infection</condition>
  <arm_group>
    <arm_group_label>Open Abdomen Management with ANPPT dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The abdominal fascia will not be closed, but a temporally abdomenal closure (TAC) dressing (such as AbThera dressing) will be placed to protect the viscera with active Negative Pressure Peritoneal drain. Formal abdominal closure or dressing change at 24-72 hours from placement should be performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Closed Abdomen Management</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Primary closure of the abdominal fascia with placement of an intra-peritoneal drain (such as a Jackson-Pratt drain). Any decision to perform a re-laparotomy will be at the discretion of the treating surgical team.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Open Abdomen Management with ANPPT dressing</intervention_name>
    <description>The abdominal fascia will not be closed, but a temporally abdominal closure (TAC) dressing, such as AbThera dressing, will be placed to protect the viscera with active Negative Pressure Peritoneal Therapy.
The time that the TAC dressing will be changed will be left to the discretion of the attending surgeon, but practice guidelines mandate either formal abdominal closure or dressing change at 24-72 hours from placement.
Blood samples and peritoneal fluid will be drawn up to 72 hours after enrollment.</description>
    <arm_group_label>Open Abdomen Management with ANPPT dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Closed Abdomen Management</intervention_name>
    <description>Primary closure of the abdominal fascia with placement of an intra-peritoneal drain (such as a Jackson-Pratt drain).
This strategy will allow drainage of intra-peritoneal fluid for both clinical reasons and to facilitate intra-peritoneal fluid testing. Closure or not of the skin will be left to the attending surgeons discretion. Any decision to perform a relaparotomy (Relaparotomy on Demand) will be at the discretion of the treating critical care teams, and in no way mandated by this recruitment.
Blood samples and peritoneal fluid (if available) will be drawn up to 72 hours after enrollment.</description>
    <arm_group_label>Closed Abdomen Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of purulent, feculent, or enteric spillage over at least 2 intra-peritoneal
             quadrants intra-operatively;

          -  Septic shock, or

          -  Predisposition-Infection-Response-Organ Dysfunction Score &gt; 3, or

          -  World-Society-of-Emergency-Surgery-Sepsis-Severity-Score &gt; 8

        Exclusion Criteria:

          -  Pregnant;

          -  Confirmed or strongly suspected severe IAH (IAP&gt;20 mmHg);

          -  No intentional of providing ongoing care;

          -  pancreatitis as the source of peritonitis;

          -  uncontrolled bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew W Kirkpatrick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Kirkpatrick, MD</last_name>
    <phone>403-944-2888</phone>
    <email>andrew.kirkpatrick@ahs.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Kirkpatrick AW, Sugrue M, McKee JL, Pereira BM, Roberts DJ, De Waele JJ, Leppaniemi A, Ejike JC, Reintam Blaser A, D'Amours S, De Keulenaer B, Malbrain MLNG. Update from the Abdominal Compartment Society (WSACS) on intra-abdominal hypertension and abdominal compartment syndrome: past, present, and future beyond Banff 2017. Anaesthesiol Intensive Ther. 2017;49(2):83-87. doi: 10.5603/AIT.a2017.0019. Epub 2017 May 14.</citation>
    <PMID>28502071</PMID>
  </reference>
  <results_reference>
    <citation>Xiao Z, Wilson C, Robertson HL, Roberts DJ, Ball CG, Jenne CN, Kirkpatrick AW. Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review. Crit Care. 2015 Oct 27;19:373. doi: 10.1186/s13054-015-1093-4. Review.</citation>
    <PMID>26502877</PMID>
  </results_reference>
  <results_reference>
    <citation>Kirkpatrick AW, Roberts DJ, Faris PD, Ball CG, Kubes P, Tiruta C, Xiao Z, Holodinsky JK, McBeth PB, Doig CJ, Jenne CN. Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial. Ann Surg. 2015 Jul;262(1):38-46. doi: 10.1097/SLA.0000000000001095.</citation>
    <PMID>25536308</PMID>
  </results_reference>
  <results_reference>
    <citation>Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, Roy S, Nieman GF. Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock. 2010 Nov;34(5):525-34. doi: 10.1097/SHK.0b013e3181e14cd2.</citation>
    <PMID>20823698</PMID>
  </results_reference>
  <results_reference>
    <citation>Opal SM, Dellinger RP, Vincent JL, Masur H, Angus DC. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med. 2014 Jul;42(7):1714-21. doi: 10.1097/CCM.0000000000000325.</citation>
    <PMID>24717456</PMID>
  </results_reference>
  <results_reference>
    <citation>Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, Duchesne J, Bjorck M, Leppaniemi A, Ejike JC, Sugrue M, Cheatham M, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh ZJ, D'Amours S, Debergh D, Kaplan M, Kimball E, Olvera C; Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013 Jul;39(7):1190-206. doi: 10.1007/s00134-013-2906-z. Epub 2013 May 15.</citation>
    <PMID>23673399</PMID>
  </results_reference>
  <results_reference>
    <citation>Reintam A, Parm P, Kitus R, Kern H, Starkopf J. Primary and secondary intra-abdominal hypertension--different impact on ICU outcome. Intensive Care Med. 2008 Sep;34(9):1624-31. doi: 10.1007/s00134-008-1134-4. Epub 2008 May 1.</citation>
    <PMID>18446319</PMID>
  </results_reference>
  <results_reference>
    <citation>Regueira T, Bruhn A, Hasbun P, Aguirre M, Romero C, Llanos O, Castro R, Bugedo G, Hernandez G. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care. 2008 Dec;23(4):461-7. doi: 10.1016/j.jcrc.2007.12.013. Epub 2008 Apr 18.</citation>
    <PMID>19056007</PMID>
  </results_reference>
  <results_reference>
    <citation>Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V, Bihari D, Innes R, Cohen J, Singer P, Japiassu A, Kurtop E, De Keulenaer BL, Daelemans R, Del Turco M, Cosimini P, Ranieri M, Jacquet L, Laterre PF, Gattinoni L. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004 May;30(5):822-9. Epub 2004 Feb 3.</citation>
    <PMID>14758472</PMID>
  </results_reference>
  <results_reference>
    <citation>De Waele JJ. Abdominal Sepsis. Curr Infect Dis Rep. 2016 Aug;18(8):23. doi: 10.1007/s11908-016-0531-z. Review.</citation>
    <PMID>27363829</PMID>
  </results_reference>
  <results_reference>
    <citation>Leppäniemi A, Kimball EJ, De Laet I, Malbrain ML, Balogh ZJ, De Waele JJ. Management of abdominal sepsis--a paradigm shift? Anaesthesiol Intensive Ther. 2015;47(4):400-8. doi: 10.5603/AIT.a2015.0026. Epub 2015 May 14. Review.</citation>
    <PMID>25973662</PMID>
  </results_reference>
  <results_reference>
    <citation>Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia. Surg Infect (Larchmt). 2015 Dec;16(6):785-93. doi: 10.1089/sur.2014.166. Epub 2015 Aug 10.</citation>
    <PMID>26258265</PMID>
  </results_reference>
  <results_reference>
    <citation>Tolonen M, Sallinen V, Mentula P, Leppäniemi A. Preoperative prognostic factors for severe diffuse secondary peritonitis: a retrospective study. Langenbecks Arch Surg. 2016 Aug;401(5):611-7. doi: 10.1007/s00423-016-1454-8. Epub 2016 May 30.</citation>
    <PMID>27241334</PMID>
  </results_reference>
  <results_reference>
    <citation>Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, Moore FA, Velmahos G, Coimbra R, Ivatury R, Peitzman A, Koike K, Leppaniemi A, Biffl W, Burlew CC, Balogh ZJ, Boffard K, Bendinelli C, Gupta S, Kluger Y, Agresta F, Di Saverio S, Wani I, Escalona A, Ordonez C, Fraga GP, Junior GA, Bala M, Cui Y, Marwah S, Sakakushev B, Kong V, Naidoo N, Ahmed A, Abbas A, Guercioni G, Vettoretto N, Díaz-Nieto R, Gerych I, Tranà C, Faro MP, Yuan KC, Kok KY, Mefire AC, Lee JG, Hong SK, Ghnnam W, Siribumrungwong B, Sato N, Murata K, Irahara T, Coccolini F, Segovia Lohse HA, Verni A, Shoko T. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013 Jan 8;8(1):3. doi: 10.1186/1749-7922-8-3.</citation>
    <PMID>23294512</PMID>
  </results_reference>
  <results_reference>
    <citation>Sartelli M, Abu-Zidan FM, Catena F, Griffiths EA, Di Saverio S, Coimbra R, Ordoñez CA, Leppaniemi A, Fraga GP, Coccolini F, Agresta F, Abbas A, Abdel Kader S, Agboola J, Amhed A, Ajibade A, Akkucuk S, Alharthi B, Anyfantakis D, Augustin G, Baiocchi G, Bala M, Baraket O, Bayrak S, Bellanova G, Beltràn MA, Bini R, Boal M, Borodach AV, Bouliaris K, Branger F, Brunelli D, Catani M, Che Jusoh A, Chichom-Mefire A, Cocorullo G, Colak E, Costa D, Costa S, Cui Y, Curca GL, Curry T, Das K, Delibegovic S, Demetrashvili Z, Di Carlo I, Drozdova N, El Zalabany T, Enani MA, Faro M, Gachabayov M, Giménez Maurel T, Gkiokas G, Gomes CA, Gonsaga RA, Guercioni G, Guner A, Gupta S, Gutierrez S, Hutan M, Ioannidis O, Isik A, Izawa Y, Jain SA, Jokubauskas M, Karamarkovic A, Kauhanen S, Kaushik R, Kenig J, Khokha V, Kim JI, Kong V, Koshy R, Krasniqi A, Kshirsagar A, Kuliesius Z, Lasithiotakis K, Leão P, Lee JG, Leon M, Lizarazu Pérez A, Lohsiriwat V, López-Tomassetti Fernandez E, Lostoridis E, Mn R, Major P, Marinis A, Marrelli D, Martinez-Perez A, Marwah S, McFarlane M, Melo RB, Mesina C, Michalopoulos N, Moldovanu R, Mouaqit O, Munyika A, Negoi I, Nikolopoulos I, Nita GE, Olaoye I, Omari A, Ossa PR, Ozkan Z, Padmakumar R, Pata F, Pereira Junior GA, Pereira J, Pintar T, Pouggouras K, Prabhu V, Rausei S, Rems M, Rios-Cruz D, Sakakushev B, Sánchez de Molina ML, Seretis C, Shelat V, Simões RL, Sinibaldi G, Skrovina M, Smirnov D, Spyropoulos C, Tepp J, Tezcaner T, Tolonen M, Torba M, Ulrych J, Uzunoglu MY, van Dellen D, van Ramshorst GH, Vasquez G, Venara A, Vereczkei A, Vettoretto N, Vlad N, Yadav SK, Yilmaz TU, Yuan KC, Zachariah SK, Zida M, Zilinskas J, Ansaloni L. Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study). World J Emerg Surg. 2015 Dec 16;10:61. doi: 10.1186/s13017-015-0055-0. eCollection 2015.</citation>
    <PMID>26677396</PMID>
  </results_reference>
  <results_reference>
    <citation>Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltrán MA, Biffl WL, Catena F, Chiara O, Coccolini F, Coimbra R, Demetrashvili Z, Demetriades D, Diaz JJ, Di Saverio S, Fraga GP, Ghnnam W, Griffiths EA, Gupta S, Hecker A, Karamarkovic A, Kong VY, Kafka-Ritsch R, Kluger Y, Latifi R, Leppaniemi A, Lee JG, McFarlane M, Marwah S, Moore FA, Ordonez CA, Pereira GA, Plaudis H, Shelat VG, Ulrych J, Zachariah SK, Zielinski MD, Garcia MP, Moore EE. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015 Aug 12;10:35. doi: 10.1186/s13017-015-0032-7. eCollection 2015. Review.</citation>
    <PMID>26269709</PMID>
  </results_reference>
  <results_reference>
    <citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 Jan;36(1):296-327. Erratum in: Crit Care Med. 2008 Apr;36(4):1394-6.</citation>
    <PMID>18158437</PMID>
  </results_reference>
  <results_reference>
    <citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008 Jan;34(1):17-60. Epub 2007 Dec 4. Erratum in: Intensive Care Med. 2008 Apr;34(4):783-5.</citation>
    <PMID>18058085</PMID>
  </results_reference>
  <results_reference>
    <citation>Slade E, Tamber PS, Vincent JL. The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care. 2003 Feb;7(1):1-2. Epub 2003 Jan 8.</citation>
    <PMID>12617727</PMID>
  </results_reference>
  <results_reference>
    <citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 Jul;29(7):1303-10.</citation>
    <PMID>11445675</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Andrew W Kirkpatrick</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>abdominal infection</keyword>
  <keyword>open abdomen management</keyword>
  <keyword>Negative pressure peritoneal therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Intraabdominal Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

